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Abstract
Introduction
Nowadays, an important decision for pregnant women is whether to undergo prenatal test-
ing for aneuploidies and which tests to uptake. We investigate the factors influencing wom-
en’s choices between non-invasive prenatal testing (NIPT) and invasive prenatal tests in
pregnancies with elevated a priori risk of fetal aneuploidies.
Methodology
This is a mixed-method study. We used medical data (1st Jan 2015-31st Dec 2015) about
women participating in further testing at Fetomaternal Medical Center at Helsinki University
Hospital and employed Chi-square tests and ANOVA to compare the groups of women
choosing different methods. Multinomial logistic regressions revealed the significant clinical
factors influencing women’s choice. We explored the underlying values, beliefs, attitudes
and other psychosocial factors that affect women’s choice by interviewing women with the
Theory of Planned Behavior framework. The semi-structured interview data were processed
by thematic analysis.
Results
Statistical data indicated that gestational age and counseling day were strong factors influ-
encing women’s choice. Interview data revealed that women’s values and moral principles
on pregnancy and childbirth chiefly determined the choices. Behavioral beliefs (e.g. safety
and accuracy) and perceived choice control (e.g. easiness, rapidness and convenience)
were also important and the major trade-offs happened between these constructs.
Discussion
Values are the determinants of women’s choice. Service availability and convenience are
strong factors. Medical risk status in this choice context is not highly influential. Choice aids
PLOS ONE | DOI:10.1371/journal.pone.0173669 March 29, 2017 1 / 15
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Chen A, Tenhunen H, Torkki P, Heinonen
S, Lillrank P, Stefanovic V (2017) Considering
medical risk information and communicating
values: A mixed-method study of women’s choice
in prenatal testing. PLoS ONE 12(3): e0173669.
doi:10.1371/journal.pone.0173669
Editor: Giuseppe Novelli, Universita degli Studi di
Roma Tor Vergata, ITALY
Received: November 22, 2016
Accepted: February 26, 2017
Published: March 29, 2017
Copyright: © 2017 Chen et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Due to the ethical and
legal restrictions required by the Ethical committee
and the agreement reached with patients that their
information will be confidential within the research
team and used for this research only, we are
unable to publicly provide the personal medical
record data and interview data underlying the
findings in our study. But excerpts of the relevant
transcripts are available on request. The excerpt
does not include any personal information about
our informants, just reporting briefly how the
woman made choices. For requesting the access to
can be developed by helping women to identify their leading values in prenatal testing and
by providing lists of value-matching test options and attributes.
Introduction
Choices in prenatal testing
As the critical component of high-quality and evidence-based prenatal care, prenatal screening
and testing helps pregnant women to establish a risk profile for their pregnancies and provides
information for birth preparations and further decisions [1, 2]. Usually, prenatal screening
and testing includes two stages. First, the risk of fetal aneuploidy is assessed with initial screen-
ing; then the screen-positive women are offered diagnostic testing to further evaluate or con-
firm aneuploidy [3, 4].
Screen-positive women have to decide whether to undergo further prenatal testing for fetal
aneuploidies and which test to take. Advances in genomic technology increase women’s
options in prenatal testing [5]. The commonly available tests include amniocentesis, chorionic
villus sampling (CVS) and the non-invasive prenatal test (NIPT)[5]. Invasive procedures,
amniocentesis and CVS, provide an accurate diagnosis but carry a miscarriage risk. In con-
trast, NIPT, which is based on next-generation sequencing of cell-free fetal DNA in maternal
plasma to assess the most common fetal aneuploidies, only uses maternal blood samples [6].
The weakness of NIPT is its false positive rates, which, although very small, require confirma-
tion of the result by invasive procedures [7].
As each test technique has its own strong and weak points, there is no universal consensus
about which test to offer [8, 9]. In line with the aim of autonomous reproductive choice, leav-
ing the choice to the women is the only solution [2, 9]. The widely accepted ideal is that prena-
tal test choices should be voluntary, autonomous and congruent with the parents’ values and
preferences [10]. However, choice-making for further tests is not easy. Testing options force
screen-positive women to make choices that are usually uncertain, difficult and even painful
[1, 11]. Thus, it is highly important to offer appropriate choice aids that allow women to make
truly autonomous choices in such context [12, 13]. So far there is still a lack of high-quality
women-centered choice aids [10], the development of which requires exploring pregnant
women’s reasoning and identifying the influential factors of women’s choice [10, 14].
Recent studies on choice-making in prenatal testing
During the last decade, several studies have been performed on women’s choice in prenatal
testing. Kenyon (2014) investigated clinical factors that potentially influence women’s uptake
on NIPT as a second-tier test [15]. The study indicated that women who received abnormal
screening results in the first trimester were more likely to choose NIPT than women receiving
results in the second trimester, and that risk scores influenced the follow-up test choice. Mane-
gold-Brauer et al. (2015) found that uptake of NIPT was influenced by economic factors and
the reimbursement of costs by the insurance companies was a significant issue affecting wom-
en’s choice [16]. Lewis et al. (2014) explored the justifications for the hypothetical decisions on
prenatal testing and they listed a number of women’s values, beliefs and attitudes associated
with testing, for example, “not wanting to risk the safety of my baby”, “my wish to have as
much information as possible about the baby” and “I felt I could cope raising a child with
Down syndrome” [17]. In their latest study, Lewis et al. (2016) empirically assessed women’s
experience of being offered NIPT and identified that reassurance was the main motivator for
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accepting NIPT [18]. Godino et al. (2013) systematically reviewed 11 studies from 2002 to
2012 regarding the factors influencing the uptake of invasive testing by women with advanced
maternal ages [19]. They suspected that psychosocial factors, maternal age, ethnicity, involve-
ment of the partner in the decision-making process, availability of prenatal tests and counsel-
ing services may influence women’s decisions.
Due to the large worldwide variety in testing and counseling protocols, generalization of
the study results is not possible. First, there are different types of testing programs and reim-
bursement plans that create different choice situations. Kenyon (2014) studied NIPT as a
second tier screening before diagnostic tests [15], while Chetty et al. (2013) studied it as an
alternative to invasive tests [8]. Second, although NIPT has been used in the field of prenatal
screening and testing for almost a decade, there is a limited number of studies to investigate
women’s choices in actual clinical practice following the adoption of NIPT. Chetty et al. (2013)
investigated women’s hypothetical attitudes on NIPT, but NIPT and invasive tests were not in
equal standing [8]. Third, many studies focused on the acceptance or uptake of NIPT or inva-
sive tests, but there is still insufficient experience on how women choose among the three
test options: NIPT, CVS and amniocentesis after positive first or second trimester screening.
Fourth, most studies employed either qualitative or quantitative methods, whereas multi-
method studies are far and few.
In this study, we design a mixed-method study to better understand how women choose
among prenatal tests—NIPT, CVS and amniocentesis—within the public maternal service
system in Finland, where all the mentioned tests are offered free of charge to screen-positive
women. Thus we can control for the monetary effects of the different tests on women’s choice-
making. We aim to share our initial experience in this particular clinical setting and demon-
strate the utilization of different testing methods.
Methods
Study context: Prenatal testing in the District of Helsinki and Uusimaa
This study was carried out at Fetomaternal Medical Center (FMC) which serves as a tertiary
center for fetal medicine in the District of Helsinki and Uusimaa (HUS). HUS was the first
Finnish public hospital to provide NIPT from the 1st of January, 2015, as an alternative to the
invasive fetal diagnostics for women with the high-risk for fetal aneuploidy either a priori
(maternal age> 40 years and first trimester combined screening unperformed for any reason
and those with the common aneuploidy in the previous pregnancy), or abnormal result in the
first trimester combined screening (risk for 21-trrisomy1:250, fetal nuchal translucency
3–3.9 mm), or abnormal second trimester screening. In a few rare cases with the presence of
two or more soft markers or fetal anomaly at the second trimester ultrasound for those who
would not terminate the pregnancy under any circumstances, NIPT has been offered as an
alternative to the invasive procedure. In such cases, the main goal was to exclude with high
probability fatal 18-and 13-trisomies, in the presence of which the cesarean delivery would be
performed only for maternal indications, if needed.
All women have been referred to an individual non-directive counseling provided by
trained midwives at FMC informing women about chromosomal conditions, their individual
risk scores, attributes of the three tests (reliability, miscarriage risk, feasibility regarding gesta-
tional age, test schedule, and waiting times for the results) and their comparisons and the
service procedures (S1 Fig). Women were offered the choice between NIPT and invasive pro-
cedures. If the result of NIPT was abnormal, no further testing was offered except the standard
second trimester genetic sonogram. In the cases of positive NIPT, post-testing counseling
was offered regarding invasive diagnostic procedure and the further pregnancy management
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according to the results. Act on Termination of Pregnancy (TOP) in Finland allows TOP up to
the gestational week 24. In case of abnormal NIPT, TOP may be performed exclusively after
the confirmation of NIPT results by invasive procedure.
A crucial service availability issue is present in the study: the NIPT sample drawing service
(blood test) is only offered on Mondays and Tuesdays at the HUS laboratory, while invasive
tests and counseling service are available across all working days. Women who had the
counseling on Wednesday/Thursday/Friday and chose NIPT had to come back for the blood
test the following Monday/Tuesday. On average, turn-over time for NIPT was around two
weeks while the results of qPCR for common trisomies were available within 3 days and the
whole karyotype within 3 weeks on average. Blood samples for NIPT were sent to the USA for
the analysis (The Harmony Prenatal Test by Ariosa Diagnostics).
Study design
In this study, we focus on the group of women who were eligible for prenatal testing because
of high risk detected by the first or the second trimester serum screening. This group
accounted for the majority of women who were eligible for further testing. Other medical indi-
cations of high risk, including abnormal nuchal translucency, previous chromosomal prob-
lems and structural abnormality, have different risk indicators, with which the analysis will
become complex. The counseling service for our study group of patients differs from those
with slightly increased NT or those who opt for NIPT or invasive due to the a-priori risk (e.g.
advanced maternal age, previous aneuploidy), so it is of great importance that all women in
our cohort represent the same group. We conducted a mixed-method research involving
quantitative data and qualitative data, which could lead to greater validity and rigor and pro-
vide a better understanding of the research problem than either research approach alone [20].
Many researchers have agreed that mixed methods approaches can be particularly useful in
healthcare research that requires a broader range of perspectives to view the complexity in this
field [21–23]. We followed the concurrent triangulation design [24], in which quantitative
study and qualitative study were conducted at the same time period and the results were con-
verged in the interpretation phase. This study was approved by HUS Ethical Committee (per-
mission number: 220/13/03/03/2015).
Quantitative study
We utilized FMC test choice database about women who participated in further testing
between 1 January 2015 and 31 December 2015. FMC patient test record includes information
about women’s choice on further tests, risk scores, maternal age, gestational age at counseling
and the counseling date. The Chi-square test (or Fisher’s Exact Test, when appropriate) was
used to compare differences in screening trimesters and counseling day (Monday and Tues-
day = 1) among women who opted for NIPT, CVS and amniocentesis. One-way ANOVAs
combined with post-hoc Scheffe tests [25] were used to detect the differences in maternal
age and gestational age at the counseling among these women who chose different tests.
Two multinomial logistic regressions, one with CVS group as the referent and the other with
amniocentesis group as the referent, helped to identify the significant factors influencing
women’s choices on the three tests, enabling the pair comparisons. Statistical analysis was per-
formed using STATA 13. A p-value of<0.05 was used to establish statistical significance.
Qualitative study
More detailed logic of women’s choice making was explored by interviewing those who partic-
ipated in further testing because of the high risk revealed by the maternal serum screening.
Factors influencing women’s choice in prenatal testing
PLOS ONE | DOI:10.1371/journal.pone.0173669 March 29, 2017 4 / 15
Midwives at the FMC participated in recruiting the interviewees after the pre-test counseling
by presenting the “letter to patient”. All the informants voluntarily participating in the inter-
views have signed the written informed consent. We continued to conduct the interviews until
we got the sample that could represent the whole population regarding the test method selec-
tions, NIPT and invasive tests. After 6 months of interviews, we deemed to have reached the
data saturation point regarding a representative sample. Semi-structured interviews included
open-ended questions about why and how the woman made choices in further testing. The
concrete questions were developed from Theory of Planned Behavior (TPB) [26, 27], which
helps to identify the determinants of women’s choice with three main constructs: behavioral
beliefs, subjective norms and perceived behavioral control. Most of the interviews were con-
ducted in Finnish and two in English. Interviews were tape recorded, transcribed, translated
into English and imported into Atlas.ti qualitative data analysis software. Author AC and
HT independently coded the data, identified the factors/items for each TPB construct (deduc-
tive analysis) and also tried to explore new constructs and corresponding factors/items
(inductive analysis). Then the two authors discussed, reached an agreement and thematically
integrated the data within the theoretical framework that was derived from TPB added with
the unearthed constructs. We enhanced the validity of findings by organizing discussions in
the research team, consulting the experts from delivery hospitals and maternal clinics, and get-
ting feedbacks from relevant parties and professionals.
Results
Results from quantitative analysis
Group differences. During the study period (1st Jan 2015-31st Dec 2015), there were 254
women (62.5% of all participants) who participated in prenatal testing with abnormal serum
screening result. NIPT was chosen by 186 women (73.2%), 39 (15.4%) chose CVS and 29
(11.4%) chose amniocentesis. Clinical characteristics of the study population with abnormal
serum screening results and following the three further tests are provided in Table 1. The sta-
tistical test showed that on average, the NIPT group had a more advanced age than the two
invasive test groups and the difference is significant (p = 0.015). The amniocentesis group had
a significantly higher gestational age than the two groups (p<0.001). Women choosing NIPT
were more likely to have counseling on Monday or Tuesday (p<0.001). Compared to amnio-
centesis choosers, CVS and NIPT choosers were more likely to have the first trimester screen-
ing (p<0.001, Fisher’s exact). No women from the second trimester screening group chose
CVS. Women choosing CVS had higher serum screening risk scores (p = 0.014).
Influential factors. Multinomial logistic regressions reveal that gestational age and
counseling day were the strong factors of women’s choice in prenatal testing, while other med-
ical factors including the trimesters of screening and serum screening risk scores were not.
Table 2 presents the RR ratios and confidence intervals (CI) of each factor. When compared to
the women choosing NIPT, women with lower gestational age were more likely to choose CVS
(p = 0.014) and women with higher gestational age were more likely to choose amniocentesis
(p<0.001). Women coming to FMC for counseling service on Monday or Tuesday were more
likely to choose NIPT over CVS (p<0.001) and amniocentesis (p = 0.028). S1 Table presents
the result of statistical power analysis for the regression by Monte Carlo simulation [28]. We
acknowledge the statistical power is not high for some variables (maternal age and serum
screening risk score) with small effect sizes in our model. However, some of the power and
effect sizes are at a good level (counseling day, screening trimester and gestational age). The
dataset we used for this study has included all women participating in the further testing at
FMC in 2015, i.e. the data of the whole population. During 2016, hospital made changes to the
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Table 1. Clinical characteristics of women choosing NIPT, CVS and amniocentesis.
Total
population
(n = 254)
NIPT
(n = 186)
CVS
(n = 39)
amniocentesis
(n = 29)
p value
(anova or chi
square test)
p value
(NIPT VS
CVS)
p value (CVS VS
amniocentesis)
p value (NIPT VS
amniocentesis)
Maternal age,
mean (SD)
35.7 (5.2) 36.2 (5.2) 35.2
(4.8)
33.3 (5.3) 0.015* 0.544 0.314 0.018*
Gestational age,
mean (SD)
100.1 (12.9) 98.9
(11.5)
92.1
(4.3)
118.2 (12.5) 0.000** 0.002** 0.000** 0.000**
Counseling day
Monday—
Tuesday, n(%)
169 (66.5%) 139
(74.7%)
14
(35.9%)
16 (55.2%) 0.000** 0.000* 0.135 0.029*
Wednesday—
Friday, n(%)
84 (33.5%) 47
(25.3%)
24
(64.1%)
13 (44.8%)
Trimester of
screening
the first
trimester
screening, n(%)
218 (85.8%) 169
(90.9%)
39
(100%)
10 (34.5%) 0.000**
(0.000**
Fisher’s exact)
0.050
(0.049*
Fisher’s
exact)
0.000**(0.000**
Fisher’s exact)
0.000**(0.000**
Fisher’s exact)
the second
trimester
screening, n(%)
36 (14.2%) 17 (9.1%) 0 (0.0%) 19 (65.5%)
Serum screening
risk score, mean
(SD)
0.022 (0.041) 0.019
(0.035)
0.041
(0.068)
0.018 (0.021) 0.014** 0.137 0.054 0.863
*p<0.05;
**p<0.01
doi:10.1371/journal.pone.0173669.t001
Table 2. Factors influencing women’s choice in prenatal testing.
Choosing NIPT vs Choosing CVS Choosing Amniocentesis vs Choosing
CVS
Choosing NIPT vs
Choosing
Amniocentesis
Predictors RRR 95(%) CI p RRR 95(%) CI p RRR 95(%) CI p
Maternal age 1.06 0.99—1.14 0.125 0.97 0.86—1.10 0.628 1.09 0.99—
1.20
0.089
Gestational age 1.09 1.02—1.17 0.014* 1.17 1.07—1.28 0.000** 0.93 0.88—
0.99
0.013*
Counseling day
—Monday or Tuesday = 1 4.47 2.04—9.85 0.000** 1.36 0.38—4.82 0.637 3.30 1.13—
9.56
0.028*
—Wednesday, Thursday or
Friday = 0
referent
Screening trimester
—The second trimester
screening = 2
84183.89 0—
(choosingCVS = 0)
0.984 230507.20 0 —
(choosingCVS = 0)
0.983 0.37 0.07—
1.92
0.235
—The first trimester screening = 1 referent
Serum screening risk score 1.00 1.00—1.01 0.135 1.00 0.99—1.01 0.510 1.01 1.00—
1.02
0.088
*p<0.05;
**p<0.01
doi:10.1371/journal.pone.0173669.t002
Factors influencing women’s choice in prenatal testing
PLOS ONE | DOI:10.1371/journal.pone.0173669 March 29, 2017 6 / 15
test service and test protocol offering invasive test and molecular karyotyping to women with
fetal nuchal translucency3.5mm and FTS risk1:10. Therefore it is hard to combine the
data of 2015 with that of following years.
Results from interviews
We interviewed 26 women (S2 Table shows the participants’ information), of which 21
(80.8%) chose NIPT, 3 (14.3%) chose CVS and 2 (7.7%) chose amniocentesis. Table 3 displays
the choice-influencing factors that were mentioned by the participants and organized within
the framework of five choice-related constructs: values, behavioral beliefs, subjective norms
and perceived choice control. It provides a picture of why women chose NIPT, CVS or amnio-
centesis and their concerns in the choice-making.
Values. Half of our interviewees had clear life-guiding and option-unaffected values
related to reproduction before participating in prenatal testing. Values include moral princi-
ples or personal normative beliefs without the facts or counseling information about the tests.
The common values mentioned by our participants included “keep the baby unconditionally
and safely obtain information for preparation”, “sequential choice, from mild to strong”,
“uncertainty avoidance” and “avoid having a sick baby”. Five women who chose NIPT claimed
that they would keep the baby in any condition and take the test to get more information
about the baby’s status and prepare for the delivery and future care. Five women said they
wanted to go through the testing sequentially starting from the less invasive option. These five
women chose NIPT first and would go to do diagnostic testing depending on the NIPT result.
Two women, one opting for CVS and the other choosing amniocentesis, suggested that they
hoped to have a healthy baby and it would be hard for them to take care of a disabled child.
One women chose amniocentesis and mentioned that she wanted everything to be controllable
in her life, suggesting the desire to obtain certainty.
Behavioral beliefs. In the interviews, we asked women about their beliefs on the advan-
tages/disadvantages of the tests they chose and explored their attitudes toward choice conse-
quences. All interviewed women had their own understandings about the attributes
(advantages or disadvantages) of their choice consequences based on the information given by
counselors or from other sources. For NIPT choosers, safety (mentioned by 20 women),
namely no miscarriage risk, was the first main factor for them to make the choice. Some NIPT
choosers (12 women) claimed that the accuracy of NIPT was high or sufficient enough for
them. Six NIPT choosers acknowledged or worried about NIPT being less accurate than other
tests. For invasive tests choosers, accuracy (mentioned by 5 women) was the dominant advan-
tage. One amniocentesis chooser emphasized the possibility of early TOP of the abnormal
fetus, the other appreciated the relative safety of amniocentesis compared to CVS. Neverthe-
less, safety (mentioned by 5 women) was the main concern the invasive tests choosers had.
Subjective norms. The interviews revealed that the women’s choices in prenatal testing
were quite individual. In such risk-involved situations, women rarely shared their experiences
with other people except for the partners. They considered it as their own right or responsibil-
ity to make the decision. Husband or partner (mentioned by 13 women) was the main person
involved in the women’s choice-making process. Twelve women said that they got support
from their husbands for the decision or it was their joint decision. One woman said she
insisted in her choice although her husband did not agree with her. Two women reported that
they contacted with friends when making the choice. One woman followed her friend’s recom-
mendation; one woman felt the friend’s choice was doubtful and she denied it affecting her
choice. Two women informed thinking about their family/extended family when they made
the decision. One woman said she followed what her relative did in the same situation, while
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Table 3. Factors that affected women’s choice on further tests in terms of values, behavioral beliefs, subjective norms and perceived choice
control.
Constructs Chose NIPT (21) Chose CVS (3) Chose amniocentesis (2) Trade-offs
For NIPT Against NIPT For CVS Against CVS For amniocentesis Against
amniocentesis
Values: moral
principle or personal
normative beliefs
without the facts or
counseling
information
Keep the baby
unconditionally and
safely obtain
information for
preparation (5) “I don’t
want to end the
pregnancy for no matter
what; I just wanted to
know more about the
baby’s status and
prepare the labor and
further care.” Sequential
choice, from mild to
strong (5) “Probably
there is nothing wrong. I
don’t want to jeopardize
the baby if there is
nothing wrong. I want to
take the stronger test
later.”
- Avoid having a sick
baby (1) “We hope to
have a healthy baby”
- Uncertainty
avoidance (1)
“Uncertainty is the
worst thing in life.”
Avoid having a sick
baby (1) “I do not want
to have a sick baby. If I
give a birth, definitively I
want a healthy baby.”
- Behavioral beliefs vs.
perceived choice
control (5) “For me the
miscarriage is the
bigger factor than the
waiting time.
Amniocentesis is faster
but the miscarriage risk
is the issue.”
Behavioral beliefs vs
behavioral beliefs (3)
“We care more about
the accuracy than the
safety and the fear of
the miscarriage risk.”
Values vs behavioral
beliefs (2)“There is
false negative risk. No
further test if the result
of NIPT is negative.
But anyway, the end
result for us is the
same. We will keep the
baby for no matter
what.” Trade-offs
between risks (1) “I
think my risk score is
low and the risk of
miscarriage of invasive
is about the same. I
don’t want to take the
risk to lose the baby.
Miscarriage from
invasive tests is more
likely than getting down
baby.”
Behavioral beliefs:
advantages/
disadvantages of
and attitude toward
different choice
consequences
Safety (20) “NIPT is not
harmful to the baby.
There is no miscarriage
risk.” Sufficient
accuracy (12) “NIPT is
sufficiently accurate for
my case.”
Accuracy (6) “NIPT is
not as accurate and
reliable as invasive
tests. There is false
negative risk.”
Accuracy (3) “CVS is
reliable and provides
certainty.”
Safety (3) “There
is miscarriage
risk in CVS.”
Accuracy (2) “I heard
that amniocentesis is
100% sure. So I wanted
to do that.” Ground for
early abortion (1) “We
cannot get abortion
based on positive NIPT.
I chose invasive test to
be able to have the
abortion as early as
possible if the baby has
problems, in order to
avoid getting too
attached to the baby.”
Safety (2) “There is
an infection and
miscarriage risk in
amniocentesis.”
Subjective norms:
social influence on
choice
Husband or partner
(10) “My decision was
supported by my
husband. Our joint
choice” Friend (1) “my
friend recommended
NIPT.” Medical staff (1)
“I had a feeling that the
midwife thought NIPT
was better for my case.”
Husband or partner
(1) “My husband
preferred
amniocentesis
because the
pregnancy has been
already 16 weeks”
Friend (1) “One of my
friends might have had
NIPT. But it does not
influence my decision,
because I was not sure
whether it was the
same situation, or she
spoke about
screening, not NIPT.”
Husband or partner
(2) “My husband
agreed with my
choice.”
- Extended family (1)
“Amniocentesis is very
common. One father’s
relative did
amniocentesis before.”
Family (1) “My sister
has different opinion
but it didn’t change
my mind”
Perceived choice
control: technical or
practical issues
related to the test
process, and
perceived ease or
difficulty of going
through the tests
Easiness (11) “NIPT is
just taking the blood
sample. It is an easy
procedure.” Comfort (7)
“NIPT is not physically as
uncomfortable as CVS,
and I don’t want the pain”
Convenience (3) “I could
take the test right away.
After the counseling I can
go straight to the blood
test” Familiarity (2)
“Taking the blood sample
is familiar to me.”
Controllability (1) “I feel
NIPT process is more
controllable than others”
Medical fact (1) “NIPT is
good for my case,
because the down risk is
small and other risk is
very small.”
Rapidness (8) “I have
to wait for two weeks to
get the test result. It is
slow.” Feasibility (1)
“NIPT may fail due to
the lack of fetal DNA in
the maternal blood.”
Rapidness (3) “It is
quick to get answer by
CVS.” Convenience
(1) “It was not
convenient to come to
the hospital again for
the NIPT test on other
day. CVS was offered
on the same day of my
counselling.”
Feasibility (1) “CVS
is feasible at this stage
of my pregnancy. The
timing is good.”
Comfort (2) “The
feeling of needle
going through the
belly and
placenta is not
good” Easiness
(1) “the
procedure is not
as easy as NIPT”
Rapidness (2) “After
the test, the result
comes in one week,
faster than NIPT”
Controllability (1) “I
was afraid of
procedure. I would
blame myself if I
moved so as to
cause problems to
the test and the
baby.”
doi:10.1371/journal.pone.0173669.t003
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another informant said she insisted in her choice despite her family not agreeing. Only one
woman described having a feeling that the medical staff was inclined to recommend certain
option and that her choice was influenced by that.
Perceived choice control. We used the perceived choice control construct to identify the
perceived ease or difficulty of going through the tests, particularly the technical or practical
factors considered by women with regard to the test process. The factors that facilitated the
women to choose NIPT include easiness of the blood sample drawing procedure (mentioned
by 11 women), less physical pain compared to the invasive tests (mentioned by 7 women), con-
venience of the testing after the pre-test counseling (mentioned by 3 women), familiarity of
the blood sample drawing procedure (mentioned by 2 women), perceived controllable process
(mentioned by 1 woman) and the low serum screening risk (mentioned by 1 woman). These
women who chose NIPT were concerned about long waiting time for the test result (men-
tioned by 8 women) and the possible failure of the test (mentioned by 1 woman). Women
chose invasive tests because of the rapidness to get the result (mentioned by 5 women), conve-
nience of the testing after the pre-test counseling (mentioned by 1 woman), and the good tim-
ing or technical feasibility of the testing according to the gestational age (mentioned by 1
woman). The main concerns held by the invasive test chooser included the pain caused by the
testing (mentioned by 2 women), the complexity of the procedure (mentioned by 1 woman)
and the possible poor controllability in the process (mentioned by 1 woman).
Trade-offs. Since no test technique can have supreme values across all aspects, trade-offs
commonly occurred as women made choice between tests, comparing the options in terms of
test attributes and putting different weights/preferences on the conflicting attributes. Trade-
offs were made between the attributes within the same construct or across different constructs.
Some women clearly expressed the perceived conflicting attributes of the different tests and
what attributes they cared more about. Two women said they insisted on their values and
made the choice based on that even though the quality of other aspects might be lost. There
was only one woman who mentioned about the risks and calculated and balanced different
risks when making the choice.
In summary, from the interview data, we found that women’s values and moral principles
on pregnancy and childbirth (keeping the baby and safely obtaining information for preparation;
sequential choice from the mild to the strong; uncertainty avoidance; avoid having a sick baby)
were the factors that predominantly determined their choices on further tests. Behavioral
beliefs (safety and accuracy) and perceived choice control (easiness, comfort, convenience, rap-
idness, feasibility, controllability and familiarity) were mainly influencing their choices. Trade-
offs between the factors were quite common. Most women made the decision by themselves,
and choices were usually supported by the partners but not strongly influenced by other
people.
Discussion
The main observation of the study is the high uptake of the NIPT in our study group of
women with high-risk for fetal aneuploidy (78.1%). Kenyon (2014) reported similar findings.
He specifically compared the uptake of diagnostic testing before and after the introduction of
NIPT and revealed the high acceptance of NIPT (70.9%) [15]. NIPT is still a relatively new
technology in prenatal testing, but it is well received, as it is viewed as a safe step to further
detect fetal aneuploidies.
Several studies have suggested that the relationship between maternal age and choice of fur-
ther tests was significant, the older the women the more likely they were to choose NIPT [15,
29]. Therefore it is surprising that in the Finnish prenatal testing context, the regressions did
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not indicate that maternal age would be a significant factor for women’s choice among the
three tests. We consider that the cut point between high and low maternal ages is not so clear
for women, as more and more women have their first child after turning 35.
Kenyon (2014) suggested that the trimester of initial screening impacted women’s choice,
speculating that selecting NIPT as a contingent screening test after the first trimester gives
women plenty of time to follow-up with a diagnostic test, while selecting NIPT after the second
trimester may give women less time to make decisions about the further step if that becomes
necessary [15]. However, in our study trimester of initial screening is not a strong factor,
because its effect on choice has been largely explained by gestational age at the counseling
moment.
According to many studies medical indications and risk detected by the screening can
guide women’s choice for further tests. Nicolaides et al. (2005) identified that the uptake rate
of invasive testing significantly increased with higher estimated risk [30]. These results are not
confirmed by our study, as traditional risk status was not a powerful factor influencing wom-
en’s choice. Most of the interviewed women did not talk about the medical risk or balance the
risk scores in their assessment, which supports the results of the statistical analysis that the
medical risk score is not a strong predictor of choice. Even with detailed counseling medical
indications and risks are very demanding to comprehend for persons with no medical back-
ground. There are different scales in women’s minds for understanding the risks, thus women
interpret the risk variedly and vaguely.
Our study indicates that when financial and reimbursement factors are removed and women
are given equal counseling about the three prenatal tests, psychological and practical factors
have stronger influencing power on women’s choice. First, choice is values-led. This construct
that is not included in the theory of planned behavior but contributes to explain significant por-
tions of variance in the choice, is values. Values refer to the overarching ethical, religious, politi-
cal, or social principles that guide how an individual lives [31, 32], the feelings of personal
responsibility regarding the performance of a given action [26], the situation-transcending fun-
damental judgment of what is most important to life [33] or the views about what is right and
wrong [34]. In this study, the prominent values with regards to the choice for the further testing
are reflected in several major themes: keeping the baby and safely obtaining information for prep-
aration; sequential choice from the mild to the strong; uncertainty avoidance; avoid having a sick
baby. Women choose NIPT if they insist in keeping the baby and safely obtaining information
for preparation or taking sequential choice from the mild to the strong, which is in line with the
findings of Gyselaers et al. (2015) that contingent NIPT screening is both clinically and econom-
ically beneficial [35]. Women choose invasive tests if they want to avoid uncertainty or having a
sick baby. Women’s values, especially ethical beliefs, assumingly play a leading role in the deci-
sion [34]. Since no treatment is available for the defects detected by the test, women receiving a
test offer are thought to be confronted with ethical questions about the values of a disabled life
and the parental responsibilities for an affected fetus. It is a common observation that women
directly associate testing decisions with potential decisions about TOP [12], which always
arouses ethical judgment. We also notice in our study that when women’s values are clear, the
choice between tests can be determined straightly, easily and with less choice burden.
Second, choice is preference-sensitive. Key attributes of the test consequences—safety,
accuracy and ground for abortion strongly influence women’s choice. Situation-specific pref-
erences on the key attributes of the tests are congruent with the personally insistent situation-
transcending values (e.g. women holding the moral principle of keeping the baby prefer the
safer test). To make the choice, women combined their values with their beliefs about the
options [36]. Once the values are clear, women would prefer the tests with the consequences
mostly meeting with the values.
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Third, choice is practice-considered. When making choices, women use self-reflection,
image the possible procedures and mentally go through testing process in order to perceive the
easiness or difficulty of it. Anticipated service experience in the procedure: easiness, rapidness,
physical comfort, controllability and familiarity influence the choice. Technical feasibility/test
timing, service availability and convenience are highly important factors influencing women’s
choice, which is revealed by both quantitative and qualitative study. When women chose the
tests, they considered the test timing and chose the test suitable to their gestational age at the
pre-test counseling moment. Women strongly prefer the test that could be performed at the
same day as the counseling service. This is supported by the study of Silcock et al (2014) in
which women expressed a strong preference for testing on the same day as the pre-test
counseling [6]. We observed that women would rather have a more risky test on the same day
than return for a safer test on a separate day. This suggests that women wish to minimize the
waiting times, as they tend to feel highly anxious about the results and medical risk informa-
tion is not as straightforward to understand as the service practicalities. The anxiety of waiting
for the test and result can be larger than the fear of miscarriage and complications related to
the invasive tests.
Fourth, choice is made by trade-offs. Presentation of the conflicting attributes of tests leads
to ambivalence and forces women to think about and make trade-offs. Women decide about
prenatal testing by waveringly putting different weights on test attributes and balance the con-
flicting ones by gradually clarifying what is more important or what is unreplaceable. Once the
reproduction-related values are certain, women have less hesitations and stress in making the
choice.
For the clinical practice, to develop prenatal testing service in Finland and elsewhere, our
results are useful in organizing tests and designing counseling, choice aids and other commu-
nications with patients. Our study’s first suggestion is that test counselors should effectively
explore women’s supreme values that could determine the choice rather than simply consider
their medical status and preferences for particular outcomes and practice [12]. Caregivers
should provide the opportunity for the women to express, discuss and clarify their values, help-
ing women to assess the meaning of testing within their life principles and then reduce deci-
sional conflicts in choice-making [37]. Second, women-friendly choice environment should be
built, which allows women to compare the information and make trade-offs between conflict-
ing attributes without much cognitive and emotional burden. Appropriate methods should be
employed to present medical information in a more concrete, visualized, comparable and
understandable way. Third, if the objective is to help women to focus more on the medical
risk, to make test attribute-based choices and not be highly influenced by the convenience of a
test, test providers should strive for removing the restrictions related to service availability and
convenience, e.g. provide tests equally in the same days.
Variations in the degree of consumer activeness and choice capabilities across patient sub-
groups have been investigated in healthcare [38–40]. Users of health services do not have an
equal capital or capability to make informed and rational choices on their own. One type of
aid cannot suit all patients. In order to provide patient-centered choice aids, service providers
(e.g. choice counselors) should consider the varying capabilities, segment the patients and
employ proper strategies or methods to assist patients’ choice exercises [41]. For aiding wom-
en’s choice-making in prenatal testing, women at pre-test counseling can be segmented into
four types based on the two dimensions: intellectual capital, referring to the knowledge in med-
icine-related fields, the ability to understand and process information and the articulation in
expressing preferences [41], and values capital, referring to the clearness and rootedness of val-
ues that women hold for life. Fig 1 presents the four segments and the specific choice aids for
each group.
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Conclusion
Our study comprehensively explored the potential factors that may influence women’s choice
in prenatal testing, especially in situations involving an elevated risk. We discovered that values
are the determinants of women’s choice. Both quantitative and qualitative study indicated that
technical feasibility and service convenience were strongly affecting women’s choice on test
methods. Women considered their gestational ages, chose the tests based on the test perfor-
mance time and preferred to have test on the same day as pre-test counseling. Our findings are
directly useful in designing choice aids and counseling structures that alleviate the burden-
some elements of prenatal testing decisions.
A lot more can be done to better understand women’s choice and reap the benefits of hav-
ing different prenatal testing methods to choose from. This study can be extended by including
women with other medical indications, e.g. abnormal nuchal translucency. A longer-term
analysis including women with more varied medical indications would provide a broader
Fig 1. Women segmentation in prenatal testing based on values capital and intellectual capital.
doi:10.1371/journal.pone.0173669.g001
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view on women’s choice in a clinical setting. A wider database is also needed to improve the
regression model. We have to acknowledge that the women who accepted to participate in our
interview have positive attitude towards research and therefore they most likely have higher
education background. This is definitely a limitation of the qualitative study with regard to
generalization of the results. We aim to improve the study by conducting survey that is distrib-
uted widely among women with different educational levels and this way we try to solve the
problem of selection bias present in this study. Surveys can help to further explore and evaluate
psychosocial factors and the weights women put on different factors.
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